Table 2.
Characteristics | Death Within 1 Year (42) | Death After 1 Year (152) | P-value |
---|---|---|---|
Age, years | |||
Median | 56.5 | 55 | 0.022 |
Range | 21–80 | 19–78 | |
Clinical history, days | |||
Median | 20 | 20 | 0.452 |
Range | 2–365 | 1–365 | |
Sex, n (%) | |||
Male | 25(59.5) | 90(59.2) | 0.971 |
Female | 17(40.5) | 62(40.8) | |
Size, cm, n (%) | |||
≤5 | 29(69.0) | 94(61.8) | 0.391 |
>5 | 13(31.0) | 58(38.2) | |
First presenting symptoms, n (%) | |||
Seizures | 2(9.1) | 20(13.2) | 0.213 |
Others | 40(95.2) | 132(86.8) | |
Tumor location, n (%) | |||
Frontal | 5(11.9) | 40(26.3) | <0.001 |
Temporal | 3(7.1) | 40(26.3) | |
Mixed | 29(69.0) | 40(26.3) | |
Others | 5(11.9) | 32(21.1) | |
NLR, n (%) | |||
≤1.706 | 4(9.5) | 46(30.3) | 0.012 |
>1.706 | 38(90.5) | 106(69.7) | |
PLR, n (%) | |||
≤87.857 | 4(9.5) | 36(23.7) | 0.073 |
>87.857 | 38(90.5) | 116(76.3) | |
LMR, n (%) | |||
≤3.067 | 11(26.2) | 56(36.8) | 0.199 |
>3.067 | 31(73.8) | 96(63.2) | |
PNI, n (%) | |||
≤56.5 | 35(83.3) | 134(88.2) | 0.409 |
>56.5 | 7(16.7) | 18(11.8) | |
AGR, n (%) | |||
≤1.908 | 14(33.3) | 47(30.9) | 0.766 |
>1.908 | 28(66.7) | 105(69.1) | |
RDW, %, n (%) | |||
≤12.8 | 5(11.9) | 47(30.9) | 0.014 |
>12.8 | 37(88.1) | 105(69.1) | |
GLC, mmol/L, n (%) | |||
≤6.57 | 32(76.2) | 134(88.2) | 0.051 |
>6.57 | 10(23.8) | 18(11.8) | |
LDH, U/L, n (%) | |||
≤182 | 16(38.1) | 96(63.2) | 0.004 |
>182 | 26(63.2) | 56(36.8) | |
FIB, g/L, n (%) | |||
≤ 3.81 | 31(73.8) | 132(86.8) | 0.041 |
>3.81 | 11(26.2) | 20(13.2) | |
DD, mg/L, n (%) | |||
≤0.183 | 28(66.7) | 122(80.3) | 0.063 |
>0.183 | 14(33.3) | 30(19.7) |
Abbreviations: NLR, the neutrophil-to-lymphocyte ratio; PLR, the platelet-to-lymphocyte ratio; LMR, the lymphocyte -to- monocyte ratio; PNI, the prognostic nutrition index; AGR, albumin-to-globulin ratio; RDW, red blood cell distribution width; GLC, glucose; LDH, lactate dehydrogenase; FIB, fibrinogen; DD, D-dimer.